Supplementary Figure S2 SET7 methylates UHRF1 in response to DNA damage and cell cycle stage is important for methylation of UHRF1
(A) HCT116 cells were exposed with 50 J/m 2 of UV, incubated for 30 min and harvested. Cell extracts of control and damaged cells were immunoprecipitated using an anti-UHRF1 antibody and associated proteins were pulled down with A/G agarose beads. Beads were washed extensively and bound proteins were resolved by SDS-PAGE, and immunoblotted using the indicated antibodies. (B) HCT116 cells were exposed to 0 or 6 Gy of IR, incubated for 30 min and harvested. Cell extracts were immunoprecipitated using an anti-SET7 antibody.
Immunoprecipitates were eluted, resolved by SDS-PAGE, and immunoblotted using the indicated antibodies. (C) HCT116 cells were exposed with 50 J/m 2 of UV and cell extracts were immunoprecipitated using an anti-UHRF1 K385me1 antibody. Immunoprecipitates were eluted, resolved by SDS-PAGE, and immunoblotted using the indicated antibodies. (D) HCT116 cells were exposed to 0-6 Gy of IR and cell extracts were immunoprecipitated using an anti-UHRF1 K385me1 antibody. Immunoprecipitates were eluted, resolved by SDS-PAGE, and immunoblotted using the indicated antibodies. (E and F) H1299 or DLD-1 cells treated with 0, 1 or 2 mM of H2O2 treatment for 30 min were immunoprecipitated using an anti-UHRF1 K385me1 antibody. Immunoprecipitates were eluted, resolved by SDS-PAGE, and 
SUPPLEMENTARY MATERIALS AND METHODS

Plasmid constructs
The UBI domain (residues 1-100), TTD-PHD domain (residues 90-383), SRA domain (residues 370-685), RING domain (residues 675-793), UHRF1 (residues 1-793), UHRF1
K385R, UHRF1 S661A, UHRF1 K670R, UHRF K385/670R, UHRF1 RING domain deletion (residues 1-600) and other mutants or partial constructs of human UHRF1, were sub-cloned into the pGFP-C1 vector (Clontech, Mountain View, CA), pLenti-G418-vector, bacterial expression vector pGEX-4T2, and a modified pcDNA6-HA-myc-his vector (Invitrogen, Carlsbad, CA). SET7 #1 (residues 1-214), SET7 #2 (residues 52-366), SET7 #3 (residues 138-366), SET7 #4 (residues 214-366), and SET7 (residues 1-366) of human SET7 (Addgene #24084) were amplified by PCR and then sub-cloned into bacterial expression vector pGEX-4T2 and a modified pcDNA6-HA-myc-his vector (Invitrogen, Carlsbad, CA). Human SET7 H297A (Addgene #24085) was purchased from Addgene. The shRNAs against human UHRF1 and SET7 were designed using siRNA sequence designer software (Clontech). A doublestranded oligonucleotide for shRNA plasmid construction was produced using primers from the 5ʹ to the 3ʹ end. The shUHRF1 and shSET7 RNA oligonucleotide sequences were as follows:
for shUHRF1: 5ʹ -CCGGAGAT ATAACGTTAGGGTTTCTCGAGAAACCCTAACGTTA TATCTTTTTTG -3ʹ (top strand) and 5ʹ-AATTCAAAAAAGATATAACGTTAGGGT TTCTCGAGAAACCCTAACGTTATATCT -3ʹ (bottom strand), for shSET7: 5ʹ-CCGGGCCAGGGTATTATTATAGAATCTCGAGATTCTATAATAATACCCTGGCTTT TT -3ʹ (top strand) and 5ʹ -AATTCAAAAAGCCAGGGTATTATTATAGAATCTCGA GATTCTATAATAATACCCTGG -3ʹ (bottom strand). 5ʹ-CCGGAGGAAGGCTCTTCT AGCAATACTCGAGTATTGCTAGAAGAGCCT TCCTTTTTTG -3ʹ (top strand) and 5ʹ-
